Overview
OncoDaily Medical Journal (ODMJ) is an international, peer-reviewed, open-access journal dedicated to advancing oncology research, clinical practice, and global cancer care. The journal is published by P53 Inc. (USA) and serves as a platform for the dissemination of high-quality, evidence-based research across the full continuum of cancer science and medicine. ODMJ acts as an official journal of the Immune Oncology Research Institute.
ODMJ was established in 2024, with its official launch announced in June 2024 as part of the expansion of OncoDaily into scholarly publishing. The journal is published online and holds the electronic ISSN 3067-6444.
ODMJ considers all submitted manuscripts under the strict condition that:
- the manuscript is the authors’ original work and does not duplicate any previously published material, including the authors’ own prior publications;
- The manuscript has been submitted exclusively to ODMJ, is not under consideration or accepted for publication by another journal, and has not been published elsewhere, except as a preprint or conference abstract. Any such prior dissemination must be disclosed at submission.
ODMJ accepts a range of manuscript types that reflect the scope of oncology research and clinical practice. All submissions must fall within the journal’s aims and scope and meet requirements of originality, scientific validity, and ethical compliance.
- Original Research Articles
- Clinical Studies and Clinical Trials
- Reviews
- Systematic Reviews and Meta-Analyses
- Short Reports / Brief Communications
- Case Reports / Case Series
- Perspectives, Opinions, and Commentaries
- Correspondence
- Editorials
- Letters to the Editor
- Trials in Progress
- Protocols
Podcasts can be provided as supplementary materials accompanying the articles.
ODMJ also publishes Special Series dedicated to selected topics in oncology, bringing together research and expert perspectives on specific areas of cancer science and care.
The ODMJ website also features a Collections section, bringing together abstracts from international congresses, conferences, and symposia in oncology.
Article Processing Charges
Currently, ODMJ does not charge authors any fees for manuscript submission, article processing, or publication.
Aims and Scope
ODMJ publishes original research articles, systematic reviews, meta-analyses, and clinical studies, as well as scholarly perspectives aimed at improving outcomes for patients with cancer worldwide. The journal emphasizes the publication of scientifically rigorous and methodologically robust research, clinically relevant and translational studies, and interdisciplinary contributions that advance the understanding, diagnosis, and treatment of cancer.
The journal covers a broad range of oncology disciplines, including molecular oncology, biomarker research, immuno-oncology, targeted therapies, clinical trials, radiation and surgical oncology, hematologic malignancies, epidemiology, real-world evidence, survivorship, palliative and supportive care, and patient-centered outcomes.
Publication Model and Frequency
ODMJ is an online-only journal operating under a continuous publication model. Peer-reviewed articles are published individually upon acceptance and completion of final production, without waiting for issue closure. Published articles are subsequently organized into annual volumes and issues for indexing, citation, and archival purposes.
Open Access Policy
ODMJ is an open access journal which means that all content is freely available without charge to the user or their institution. Users are allowed to read, download, copy, search, or link to the full texts of the articles, without asking prior permission from the publisher or the author.
Copyright and Licensing
ODMJ is an open-access journal. All scholarly articles are freely available online immediately upon publication under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors retain copyright in their articles and grant ODMJ a non-exclusive right to publish and distribute the article. Under CC BY 4.0, articles may be shared, adapted, and reused for any purpose, including commercial use, provided appropriate credit is given to the original author(s) and source. No additional restrictions are imposed beyond the terms of the CC BY 4.0 license.
Self-Archiving and Repository Policy
Authors may deposit the submitted manuscript (preprint), accepted manuscript, and published version of record in an institutional, subject, or other repository of their choice without embargo. Upon publication, deposited versions should include the full citation and DOI link to the published article. The published version is distributed under the CC BY 4.0 license.
Archiving and Preservation
Published articles are accessible through the journal’s online archive. ODMJ does not currently use an external long-term digital preservation service.
Privacy Statement
Personal information provided through the ODMJ website is used only for legitimate journal, publishing, editorial, administrative, and website-operational purposes. Personal data are processed in accordance with the ODMJ Privacy Policy and are not sold to third parties.
Indexing & Abstracting